Monroe Capital (MRCC) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
5 Mar, 2026Executive summary
Reported fourth quarter 2025 net investment income (NII) of $2.2 million ($0.10 per share) and adjusted NII of $2.3 million ($0.11 per share), with full year 2025 NII of $11.4 million ($0.53 per share) and adjusted NII of $11.6 million ($0.54 per share).
Net asset value (NAV) declined to $166.5 million ($7.68 per share) at year-end, down from $173.0 million ($7.99 per share) at September 30, 2025.
Announced a proposed merger with Horizon Technology Finance Corporation (HRZN), anticipated to close near the end of Q1 or early Q2 2026.
Quarterly dividend of $0.18 per share paid on December 31, 2025; first quarter 2026 distribution set at $0.09 per share.
Financial highlights
Total investment income for Q4 2025 was $8.2 million, flat sequentially; full year 2025 investment income was $37.9 million, down from $60.5 million in 2024.
Total expenses for Q4 2025 were $5.9 million, down from $6.4 million in Q3 2025; full year expenses were $26.5 million, down from $36.0 million in 2024.
Net loss for Q4 2025 was $4.9 million, compared to $3.0 million in Q3 2025; full year net loss was $16.5 million, compared to $14.8 million in 2024.
Portfolio fair value at year-end was $334.9 million, down from $360.7 million at September 30, 2025.
Outlook and guidance
Management expects the merger with HRZN to unlock value, provide scale, and offer access to broader funding solutions and potential for higher dividends.
Dividend adjusted to align with net investment income due to lower base rates and in anticipation of the merger.
Latest events from Monroe Capital
- Both asset sale and merger proposals were approved by a majority of outstanding shares.MRCC
EGM 202613 Mar 2026 - Supplemental distributions and enhanced merger terms were approved to address shareholder concerns.MRCC
Proxy Filing11 Mar 2026 - Supplement updates proxy materials for a proposed transaction, referencing recent filings.MRCC
Proxy Filing6 Mar 2026 - Director election and share sale authorization approved; no shareholder questions raised.MRCC
AGM 20243 Feb 2026 - Adjusted NII rose to $0.31/share, covering the dividend as NAV and leverage declined.MRCC
Q2 20242 Feb 2026 - Shareholders to vote on merger and asset sale, with NAV-based share exchange and fee waiver.MRCC
Proxy Filing20 Jan 2026 - Dividend coverage strong, NAV dipped, non-accruals up, Wendel partnership adds $1B capital.MRCC
Q3 202414 Jan 2026 - Q4 income covered dividends; NAV dipped, but 2025 outlook targets growth and risk discipline.MRCC
Q4 202416 Dec 2025 - Shareholders to vote on unchanged advisory agreement after Wendel acquires 75% of Monroe.MRCC
Proxy Filing2 Dec 2025